Variant report

Variant	esv3390375
Chromosome Location	chr2:48755948-48758496
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:188)
CpG islands
(count:366)
Chromatin interactive
region (count:0)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:188 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CCNT2	chr2:48757262-48757674	K562	blood:	n/a	n/a
2	CTBP2	chr2:48757318-48757798	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr2:48757426-48757647	K562	blood:	n/a	n/a
4	CTCF	chr2:48757460-48757610	GM12873	blood:	n/a	n/a
5	CTCF	chr2:48757620-48757770	HMEC	breast:	n/a	n/a
6	CTCF	chr2:48757420-48757605	K562	blood:	n/a	n/a
7	CTCF	chr2:48756500-48756650	SK-N-SH_RA	brain:	n/a	n/a
8	CTCF	chr2:48757460-48757610	GM12868	blood:	n/a	n/a
9	CTCF	chr2:48757419-48757779	K562	blood:	n/a	n/a
10	CTCF	chr2:48757400-48757550	WERI-Rb-1	eye:	n/a	n/a
11	CTCF	chr2:48757480-48757630	GM12875	blood:	n/a	n/a
12	CTCF	chr2:48757520-48757670	GM12870	blood:	n/a	n/a
13	CTCF	chr2:48757460-48757610	SAEC	small airway:	n/a	n/a
14	CTCF	chr2:48757435-48757668	IMR90	lung:	n/a	n/a
15	CTCF	chr2:48757460-48757610	Caco-2	colon:	n/a	n/a
16	CTCF	chr2:48756480-48756630	WERI-Rb-1	eye:	n/a	n/a
17	CTCF	chr2:48757540-48757690	HPAF	blood vessel:	n/a	n/a
18	CTCF	chr2:48757400-48757550	HPAF	blood vessel:	n/a	n/a
19	CTCF	chr2:48757400-48757550	HUVEC	blood vessel:	n/a	n/a
20	CTCF	chr2:48757440-48757590	GM12872	blood:	n/a	n/a
21	CTCF	chr2:48757480-48757630	WERI-Rb-1	eye:	n/a	n/a
22	CTCF	chr2:48757500-48757650	AG09319	gingival:	n/a	n/a
23	CTCF	chr2:48757540-48757690	GM12871	blood:	n/a	n/a
24	CTCF	chr2:48757400-48757550	HFF-Myc	foreskin:	n/a	n/a
25	CTCF	chr2:48757400-48757550	GM12871	blood:	n/a	n/a
26	CTCF	chr2:48757700-48757850	HVMF	connective:	n/a	n/a
27	CTCF	chr2:48757500-48757650	AoAF	blood vessel:	n/a	n/a
28	CTCF	chr2:48757560-48757710	GM12864	blood:	n/a	n/a
29	CTCF	chr2:48757400-48757550	HCPEpiC	choroid plexus:	n/a	n/a
30	CTCF	chr2:48757400-48757550	NHEK	skin:	n/a	n/a
31	CTCF	chr2:48757440-48757590	WI-38	lung:	n/a	n/a
32	CTCF	chr2:48757420-48757570	HCFaa	heart:	n/a	n/a
33	CTCF	chr2:48757440-48757590	HUVEC	blood vessel:	n/a	n/a
34	CTCF	chr2:48757380-48757530	GM12867	blood:	n/a	n/a
35	CTCF	chr2:48757386-48757623	HepG2	liver:	n/a	n/a
36	CTCF	chr2:48757480-48757630	NHDF-neo	bronchial:	n/a	n/a
37	CTCF	chr2:48757460-48757610	HEK293	kidney:	n/a	n/a
38	CTCF	chr2:48757460-48757610	HCM	heart:	n/a	n/a
39	CTCF	chr2:48757520-48757670	HFF	foreskin:	n/a	n/a
40	CTCF	chr2:48757520-48757670	A549	lung:	n/a	n/a
41	CTCF	chr2:48757300-48757450	HAc	cerebellar:	n/a	n/a
42	CTCF	chr2:48757400-48757550	SK-N-SH_RA	brain:	n/a	n/a
43	CTCF	chr2:48757500-48757650	HepG2	liver:	n/a	n/a
44	CTCF	chr2:48757540-48757690	RPTEC	kidney:	n/a	n/a
45	CTCF	chr2:48757480-48757630	HCM	heart:	n/a	n/a
46	CTCF	chr2:48757400-48757550	GM12874	blood:	n/a	n/a
47	CTCF	chr2:48757440-48757590	HAc	cerebellar:	n/a	n/a
48	CTCF	chr2:48757480-48757630	AoAF	blood vessel:	n/a	n/a
49	CTCF	chr2:48757520-48757670	HRPEpiC	eye:	n/a	n/a
50	CTCF	chr2:48757520-48757670	GM12873	blood:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:48757722-48757772	ECC-1	luminal epithelium:	n/a
2	chr2:48756994-48757044	AoSMC	blood vessel:	n/a
3	chr2:48756079-48756129	NT2-D1	testis:	n/a
4	chr2:48756994-48757044	Caco-2	colon:	n/a
5	chr2:48756994-48757044	ECC-1	luminal epithelium:	n/a
6	chr2:48757722-48757772	HRPEpiC	eye:	n/a
7	chr2:48756994-48757044	Jurkat	blood:	n/a
8	chr2:48756079-48756129	SAEC	small airway:	n/a
9	chr2:48756994-48757044	Hela-S3	cervix:	n/a
10	chr2:48757694-48757744	K562	blood:	n/a
11	chr2:48756994-48757044	HNPCEpiC	eye:	n/a
12	chr2:48757722-48757772	HIPEpiC	eye:	n/a
13	chr2:48756994-48757044	GM12891	blood:	n/a
14	chr2:48756079-48756129	SK-N-SH_RA	brain:	n/a
15	chr2:48757722-48757772	GM06990	blood:	n/a
16	chr2:48756079-48756129	GM06990	blood:	n/a
17	chr2:48757477-48757527	Jurkat	blood:	n/a
18	chr2:48756079-48756129	HNPCEpiC	eye:	n/a
19	chr2:48757477-48757527	GM06990	blood:	n/a
20	chr2:48757694-48757744	HRCEpiC	kidney:	n/a
21	chr2:48757694-48757744	AG09309	skin:	n/a
22	chr2:48756079-48756129	U87	brain:	n/a
23	chr2:48757477-48757527	HIPEpiC	eye:	n/a
24	chr2:48757694-48757744	NHDF-neo	bronchial:	n/a
25	chr2:48756079-48756129	HEEpiC	esophagus:	n/a
26	chr2:48757694-48757744	HUVEC	blood vessel:	n/a
27	chr2:48756994-48757044	GM19239	blood:	n/a
28	chr2:48757477-48757527	MCF10A-Er-Src	breast:	n/a
29	chr2:48757722-48757772	HCF	heart:	n/a
30	chr2:48757477-48757527	HepG2	liver:	n/a
31	chr2:48756079-48756129	HEK293	kidney:	embryo
32	chr2:48757722-48757772	Hela-S3	cervix:	n/a
33	chr2:48756079-48756129	HL-60	blood:	n/a
34	chr2:48756994-48757044	HMEC	breast:	n/a
35	chr2:48756994-48757044	Hepatocyte	liver:	n/a
36	chr2:48757612-48757662	SK-N-MC	brain:	n/a
37	chr2:48756994-48757044	AG10803	skin:	n/a
38	chr2:48757694-48757744	HL-60	blood:	n/a
39	chr2:48757722-48757772	AG04450	lung:	fetal
40	chr2:48756079-48756129	IMR90	lung:	fetal
41	chr2:48757694-48757744	HPAEpiC	pulmonary alveolar:	n/a
42	chr2:48756994-48757044	AG04449	skin:	fetal
43	chr2:48757694-48757744	HepG2	liver:	n/a
44	chr2:48757694-48757744	IMR90	lung:	fetal
45	chr2:48757477-48757527	SKMC	muscle:	n/a
46	chr2:48757477-48757527	HCF	heart:	n/a
47	chr2:48756994-48757044	LNCaP	prostate:	n/a
48	chr2:48757477-48757527	AG10803	skin:	n/a
49	chr2:48757477-48757527	IMR90	lung:	fetal
50	chr2:48757612-48757662	GM12891	blood:	n/a

No data

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-STON1-1	chr2:48757019-48757187	NONHSAT070624
2	lnc-STON1-1	chr2:48757019-48759056	NONHSAT070625
3	lnc-STON1-1	chr2:48756522-48756726	NONHSAT070625
4	lnc-STON1-1	chr2:48757737-48757968	NONHSAT070624
5	lnc-STON1-1	chr2:48757309-48757355	NONHSAT070624

No data

Variant related genes	Relation type
STON1	TF binding region
STON1-GTF2A1L	TF binding region
STON1	CpG island
STON1-GTF2A1L	CpG island

Extended variants
information (count: 89 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:89 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs77902227	chr2:48755968-48755969	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs527937123	chr2:48755980-48755981	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs144990297	chr2:48755981-48755982	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs567654054	chr2:48756028-48756029	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs551447482	chr2:48756052-48756053	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs550275628	chr2:48756059-48756060	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs571741199	chr2:48756142-48756143	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs539653850	chr2:48756155-48756156	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs148677320	chr2:48756161-48756162	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs142216783	chr2:48756175-48756176	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs534085583	chr2:48756210-48756211	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs147852799	chr2:48756282-48756283	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs141496043	chr2:48756300-48756301	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs373401071	chr2:48756309-48756310	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs560400073	chr2:48756342-48756343	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs192402443	chr2:48756359-48756360	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs147042196	chr2:48756371-48756372	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs577275183	chr2:48756396-48756397	Flanking Active TSS Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs147684853	chr2:48756421-48756422	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs560732792	chr2:48756459-48756460	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs572689293	chr2:48756478-48756479	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs78151697	chr2:48756479-48756480	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs531759577	chr2:48756485-48756486	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs375109994	chr2:48756496-48756497	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs6733533	chr2:48756555-48756556	Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Active TSS	TF binding region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
26	rs565381750	chr2:48756617-48756618	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
27	rs532636335	chr2:48756620-48756621	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
28	rs369697380	chr2:48756637-48756638	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
29	rs373511025	chr2:48756640-48756641	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
30	rs34461314	chr2:48756682-48756683	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
31	rs370695220	chr2:48756772-48756773	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
32	rs566645736	chr2:48756784-48756785	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs533873332	chr2:48756895-48756896	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs60255199	chr2:48756896-48756897	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs567191664	chr2:48756945-48756946	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs548291429	chr2:48756948-48756949	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs537454426	chr2:48756954-48756955	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs184860682	chr2:48756967-48756968	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs374361730	chr2:48756986-48756987	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs377169806	chr2:48756996-48756997	Active TSS Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
41	rs370621683	chr2:48757035-48757036	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region CpG island lncRNA	2 gene(s)	Overlapped CNVs	n/a
42	rs374133875	chr2:48757048-48757049	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
43	rs367718920	chr2:48757057-48757058	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
44	rs188113957	chr2:48757081-48757082	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
45	rs372632962	chr2:48757097-48757098	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
46	rs201429893	chr2:48757105-48757106	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs573612793	chr2:48757184-48757185	Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs192357652	chr2:48757264-48757265	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs116061481	chr2:48757288-48757289	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs561583356	chr2:48757303-48757304	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Williams Syndrome	20824207	CNVD
Breast cancer	16272173	CNVD
Lung cancer	17297452	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20433910	CNVD
Autism	21701786	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Austim spectrum disorder	21302340	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	20553308	CNVD
Autism	22241247	CNVD
Myelofibrosis	22110671	CNVD
Lung adenocarcinoma	17086460	CNVD
Retinoblastoma	22278416	CNVD
Cancer	21183584	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	18768390	CNVD
Mental retardation	19521722	CNVD
Schizophrenia	18990708	CNVD
Schizophrenia	18940311	CNVD
Schizophrenia	19348701	CNVD
Schizophrenia	18945720	CNVD
Schizophrenia	19571808	CNVD
Prostate cancer	16573809	CNVD
Neuroticism	17667963	CNVD
Schizophrenia	19443537	CNVD
Schizophrenia	19546859	CNVD
Autism	17322880	CNVD
Lung cancer	17086460	CNVD
Chronic lymphocytic leukemia	17053054	CNVD
Hereditary non-polyposis colorectal cancer	19566914	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	22522925	CNVD
T-cell lymphomas	22341440	CNVD

Chromatin state (count:539 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:48726400-48756800	Weak transcription	Placenta Amnion	Placenta Amnion
2	chr2:48728200-48756800	Weak transcription	HMEC	breast
3	chr2:48737800-48756200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr2:48738000-48756800	Weak transcription	NH-A	brain
5	chr2:48740000-48756000	Weak transcription	H9 Cell Line	embryonic stem cell
6	chr2:48740000-48757600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
7	chr2:48742400-48756200	Weak transcription	NHDF-Ad	bronchial
8	chr2:48743200-48756000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
9	chr2:48743200-48756200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr2:48743200-48756800	Weak transcription	Stomach Mucosa	stomach
11	chr2:48743400-48756200	Weak transcription	H1 Cell Line	embryonic stem cell
12	chr2:48743400-48756400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
13	chr2:48743400-48757400	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
14	chr2:48743400-48757400	Weak transcription	Gastric	stomach
15	chr2:48744000-48756600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr2:48744000-48756800	Weak transcription	Colonic Mucosa	Colon
17	chr2:48744600-48756400	Weak transcription	Brain Germinal Matrix	brain
18	chr2:48744800-48756200	Weak transcription	Fetal Brain Female	brain
19	chr2:48745200-48756200	Weak transcription	Esophagus	oesophagus
20	chr2:48745600-48756800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
21	chr2:48745800-48756400	Weak transcription	Primary hematopoietic stem cells	blood
22	chr2:48745800-48756400	Weak transcription	Muscle Satellite Cultured Cells	--
23	chr2:48745800-48756400	Weak transcription	Brain Angular Gyrus	brain
24	chr2:48745800-48756400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
25	chr2:48746000-48756400	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
26	chr2:48746000-48756400	Weak transcription	A549	lung
27	chr2:48746000-48756400	Weak transcription	HSMM	muscle
28	chr2:48746400-48756400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
29	chr2:48746800-48756600	Weak transcription	Osteobl	bone
30	chr2:48746800-48756800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
31	chr2:48747000-48756000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
32	chr2:48747000-48756800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
33	chr2:48747000-48756800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
34	chr2:48748200-48756400	Weak transcription	Duodenum Mucosa	Duodenum
35	chr2:48748200-48756400	Weak transcription	GM12878-XiMat	blood
36	chr2:48748200-48756800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
37	chr2:48748200-48756800	Weak transcription	NHEK	skin
38	chr2:48748400-48756000	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
39	chr2:48748600-48756200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
40	chr2:48748600-48756400	Weak transcription	Dnd41	blood
41	chr2:48748800-48756400	Weak transcription	Rectal Mucosa Donor 29	rectum
42	chr2:48749400-48756200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
43	chr2:48749400-48756400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
44	chr2:48749400-48756400	Weak transcription	Primary T helper cells fromperipheralblood	blood
45	chr2:48749400-48756400	Weak transcription	Fetal Thymus	thymus
46	chr2:48749400-48756400	Weak transcription	Thymus	Thymus
47	chr2:48749600-48756200	Weak transcription	Primary T helper cells PMA-I stimulated	--
48	chr2:48749600-48756200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
49	chr2:48749600-48756200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr2:48749600-48756800	Weak transcription	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links